Salford Royal NHS Foundation Trust in the UK has ordered a second CARESTREAM DRX-Revolution Mobile X-ray System for use in their new Hope building, part of the Trust's GBP 200 million (Euro 230 million) redevelopment scheme to improve the hospital site. 
Snore much? Beware: it's one of the key signs of a disorder that may lead to serious chronic diseases, including diabetes or heart disease. In an effort to help obstructive sleep apnea (OSA) sufferers identify and combat the disorder, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) will screen one million people worldwide for OSA over the next five years. 
Continua Health Alliance announced that Elinaz Mahdavy, European Affairs and Strategic Partnerships Manager at Orange Healthcare, has been unanimously elected chair of its European Working Group. Elinaz will lead Continua's outreach and relations with EU institutions and government entities in Europe. She succeeds Mário Romão, senior policy manager at Intel, who will continue to serve as vice chair. Carestream announced new measurement tools for chiropractic professionals that make its CR systems with acquisition/mini-PACS software an even more attractive and efficient digital image capture and management solution. These systems can be purchased from Carestream or through their authorised Carestream dealers. 
iPLATO Healthcare, a UK leader in mHealth, revealed that the number of patients connected to its platform surpassed five million in late 2012. Working in partnership with healthcare commissioners, commissioning support teams and practices iPLATO added over 5,000 patients per day to the platform in 2012. Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced the results of an extensive new scientific study into sleep apnea, conducted over the last two years by Philips in collaboration with University of Twente (Enschede, the Netherlands), Medisch Spectrum Twente Hospital (Enschede, the Netherlands), and patients' organization ApneuVereniging.